A rare and incurable form of non-Hodgkin lymphoma, mantle cell lymphoma (MCL) is a very heterogeneous disease that does not fit cleanly into the indolent/aggressive category. Like other subtypes of non-Hodgkin lymphoma, however, overall response rates and duration of responses decrease with subsequent lines of therapy.
During the NCCN 2022 Annual Congress: Hematologic Malignancies, Tycel Phillips, MD, an associate clinical professor in lymphoma at the City of Hope National Medical Center,